BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16005575)

  • 21. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Megavoltage CT in helical tomotherapy - clinical advantages and limitations of special physical characteristics.
    Sterzing F; Kalz J; Sroka-Perez G; Schubert K; Bischof M; Roder F; Debus J; Herfarth K
    Technol Cancer Res Treat; 2009 Oct; 8(5):343-52. PubMed ID: 19754210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
    Barker JL; Garden AS; Ang KK; O'Daniel JC; Wang H; Court LE; Morrison WH; Rosenthal DI; Chao KS; Tucker SL; Mohan R; Dong L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):960-70. PubMed ID: 15234029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for predicting lung cancer response to therapy.
    Seibert RM; Ramsey CR; Hines JW; Kupelian PA; Langen KM; Meeks SL; Scaperoth DD
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):601-9. PubMed ID: 17236977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.
    Shih HA; Jiang SB; Aljarrah KM; Doppke KP; Choi NC
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):613-22. PubMed ID: 15380599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of intrafractional organ motion by megavoltage computed tomography in patients with lung cancer treated with image-guided stereotactic body radiotherapy using helical tomotherapy.
    Aibe N; Yamazaki H; Nishimura T; Oota Y; Iwama K; Nakamura S; Ikeno H; Yoshida K; Okabe H; Yamada K
    Anticancer Res; 2014 Dec; 34(12):7383-8. PubMed ID: 25503177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy.
    Lim G; Bezjak A; Higgins J; Moseley D; Hope AJ; Sun A; Cho JB; Brade AM; Ma C; Bissonnette JP
    J Thorac Oncol; 2011 Mar; 6(3):531-6. PubMed ID: 21258244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the influence of breathing on the movement and modeling of lung tumors.
    Allen AM; Siracuse KM; Hayman JA; Balter JM
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1251-7. PubMed ID: 15001270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep-inspiration breath-hold kilovoltage cone-beam CT for setup of stereotactic body radiation therapy for lung tumors: initial experience.
    Duggan DM; Ding GX; Coffey CW; Kirby W; Hallahan DE; Malcolm A; Lu B
    Lung Cancer; 2007 Apr; 56(1):77-88. PubMed ID: 17169461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC).
    Cheung PC; Sixel KE; Tirona R; Ung YC
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1437-42. PubMed ID: 14630283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography.
    Britton KR; Starkschall G; Tucker SL; Pan T; Nelson C; Chang JY; Cox JD; Mohan R; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1036-46. PubMed ID: 17379442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors.
    Stroom J; Blaauwgeers H; van Baardwijk A; Boersma L; Lebesque J; Theuws J; van Suylen RJ; Klomp H; Liesker K; van Pel R; Siedschlag C; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):267-75. PubMed ID: 17707281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of primary renal lymphoma using image guided helical tomotherapy.
    Renaud J; Yartsev S; Dar AR; Van Dyk J
    Can J Urol; 2009 Jun; 16(3):4639-47. PubMed ID: 19497170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.
    Sterzing F; Schubert K; Sroka-Perez G; Kalz J; Debus J; Herfarth K
    Strahlenther Onkol; 2008 Jan; 184(1):8-14. PubMed ID: 18188517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tomotherapeutic stereotactic body radiation therapy: Techniques and comparison between modalities.
    Fuss M; Shi C; Papanikolaou N
    Acta Oncol; 2006; 45(7):953-60. PubMed ID: 16982563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC.
    van Sörnsen de Koste JR; Senan S; Underberg RW; Oei SS; Elshove D; Slotman BJ; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):334-9. PubMed ID: 16168828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.